GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CA4DP | combretastatin A4 phosphate | fosbretabulin disodium | fosbretabulin tromethamine | Zybrestat (fosbretabulin disodium)
Compound class:
Synthetic organic
Comment: Fosbretabulin is being investigated for anti-tumour potential. It interferes with vascularisation by preventing tubulin-polymerisation and disrupting cell junctions [2]. This action destroys tumour vasculature and leads to cancer cell death and necrosis. Mechanistically, fosbretabulin is dephosphorylated to the active tubulin polymerisation inhibitor combretastatin A4 [3]. The compound was originally isolated from the African bush willow (Combretum caffrum) [1,5].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Is prodrug? | Yes |
| Active form | combretastatin A4 |
IUPAC Name ![]() |
| [2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8966 | fosbretabulin |
Synonyms ![]() |
| CA4DP | combretastatin A4 phosphate | fosbretabulin disodium | fosbretabulin tromethamine | Zybrestat (fosbretabulin disodium) |
Database Links ![]() |
|
| CAS Registry No. | 222030-63-9 |
| ChEMBL Ligand | CHEMBL1206232 |
| GtoPdb PubChem SID | 252827514 |
| PubChem CID | 5351387 |
| Search Google for chemical match using the InChIKey | WDOGQTQEKVLZIJ-WAYWQWQTSA-N |
| Search Google for chemicals with the same backbone | WDOGQTQEKVLZIJ |
| Search PubMed clinical trials | fosbretabulin |
| Search PubMed titles | fosbretabulin |
| Search PubMed titles/abstracts | fosbretabulin |
| UniChem Compound Search for chemical match using the InChIKey | WDOGQTQEKVLZIJ-WAYWQWQTSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | WDOGQTQEKVLZIJ-WAYWQWQTSA-N |